SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.18-1.4%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: celeryroot.com who wrote (15590)2/21/1998 7:06:00 PM
From: Machaon  Read Replies (1) of 32384
 
<< Bob, is that the British spelling ? :) >>

Actually, yes. Bob is spelled the same way in England: Bob.

However, backwards, it does not have the same British spelling.

Hmmmm!? Just checking out LGND's capitalization. The "Groups" service here on SI gives some nice comparative stats. But, it would be nice to compare capitalizations based on pipelines, affiliations, revenue expectations, etc.

For instance: If you compare LGND's Targretin partner Eli Lilly's capitalization of $70,146.6 million (a full blown drug company), with LGND's capitalization of $514.3 million; LLY is valued at 136 times LGND. If LGND can grow into a LLY, it would be worth almost $2000 per share.

Of course, if frogs had wings, they could fly.

Regards, Bob

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext